We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPBI
3751
DELISTED
Pacific Premier Bancorp
PPBI
$28K ﹤0.01%
1,396
-8,092
-85% -$171K
RSPT icon
3752
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$6.01B
$28K ﹤0.01%
1,330
-106,970
-99% -$2.23M
SAR icon
3753
Saratoga Investment
SAR
$304M
$28K ﹤0.01%
+1,690
New +$28.8K
NEPT
3754
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$28K ﹤0.01%
10
+7
+233% +$26.7K
ATNX
3755
DELISTED
Athenex, Inc. Common Stock
ATNX
$28K ﹤0.01%
115
-386
-77% -$92.7K
FLXN
3756
DELISTED
Flexion Therapeutics, Inc.
FLXN
$28K ﹤0.01%
2,719
-7,491
-73% -$91.8K
BCH icon
3757
Banco de Chile
BCH
$20.6B
$27K ﹤0.01%
1,785
-769
-30% -$13.4K
ENIC icon
3758
Enel Chile
ENIC
$6.27B
$27K ﹤0.01%
+7,727
New +$29.4K
FRME icon
3759
First Merchants
FRME
$2.74B
$27K ﹤0.01%
1,169
-5,488
-82% -$137K
GNLN icon
3760
Greenlane Holdings
GNLN
$1.22M
0
HBM icon
3761
Hudbay
HBM
$11.9B
$27K ﹤0.01%
6,498
-7,245
-53% -$27.9K
HFRO
3762
Highland Opportunities and Income Fund
HFRO
$400M
$27K ﹤0.01%
+3,096
New +$26.1K
PANL icon
3763
Pangaea Logistics
PANL
$487M
$27K ﹤0.01%
10,520
-30,991
-75% -$71.1K
SRTY icon
3764
ProShares UltraPro Short Russell2000
SRTY
$65.3M
$27K ﹤0.01%
32
+12
+60% +$10.8K
TKC icon
3765
Turkcell
TKC
$4.75B
$27K ﹤0.01%
+5,729
New +$30K
VST icon
3766
Vistra
VST
$49.7B
$27K ﹤0.01%
1,398
-11,763
-89% -$222K
DM
3767
DELISTED
Desktop Metal, Inc.
DM
$27K ﹤0.01%
253
+242
+2,200% +$26.2K
ALNA
3768
DELISTED
Allena Pharmaceuticals
ALNA
$27K ﹤0.01%
+18,122
New +$25.5K
ETTX
3769
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$27K ﹤0.01%
13,120
+4,372
+50% +$12.5K
YELL
3770
DELISTED
Yellow Corporation Common Stock
YELL
$27K ﹤0.01%
6,798
-1,824
-21% -$6.68K
AYTU icon
3771
AYTU BioPharma
AYTU
$25.5M
$26K ﹤0.01%
109
+92
+541% +$23.6K
CRVS icon
3772
Corvus Pharmaceuticals
CRVS
$1.25B
$26K ﹤0.01%
6,450
+4,596
+248% +$18.4K
ERIE icon
3773
Erie Indemnity
ERIE
$13.4B
$26K ﹤0.01%
126
-1,765
-93% -$370K
NAK
3774
Northern Dynasty Minerals
NAK
$908M
$26K ﹤0.01%
27,269
+24,569
+910% +$33.8K
NEA icon
3775
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.4B
$26K ﹤0.01%
1,831

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.